PsyPost on MSN8 天
New intranasal RNA therapy shows promise in boosting memory and reducing anxiety
A recent study published in Genomic Psychiatry has unveiled a promising new therapy that may help improve memory and reduce ...
labiotech10 小时
RNA editing in humans: the race begins with first successful trial
RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.
BioWorld2 天
First-in-class antisense RNA therapy for BK virus presented
Patients receiving a kidney transplant and who are positive for BK virus (BKV) are at risk of losing their transplant due to BKV reactivation. At this time, there are no antiviral options available ...
BioPharma Dive1 天
RNA editing: emerging from CRISPR’s shadow
Early data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such ...
Muscular Dystrophy News6 天
RNA-based approach shows promise for DM1 in cell models
Treatment with an RNA-based therapy approach was found to correct molecular defects in a cell model of myotonic dystrophy ...
Too Old to Operate8 天
ANGPLT3 interfering RNA therapy reduces triglyceride levels in mixed hyperlipidemia
Zodasiran, an RNA interference (RNAi) therapy targeting angiopoietin-like 3 (ANGPTL3), resulted in a dose-dependent reduction ...
GEN2 天
StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR
Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...
PharmTech2 天
AAPS PharmSci 306: Trends in New Analytical Tools for RNA Characterization
Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for ...